871700-18-4 Usage
General Description
1-cyclopropyl-3-(2-fluoro-4-iodophenyl)urea is a chemical compound with the molecular formula C10H10FN2OI. It is a urea derivative with a cyclopropyl group and a substituted phenyl ring containing both fluorine and iodine. 1-cyclopropyl-3-(2-fluoro-4-iodophenyl)urea is commonly used in pharmaceutical research and drug development, particularly in the field of anti-cancer and anti-inflammatory medications. Its unique molecular structure and functional groups make it a valuable tool for studying the structure-activity relationships of potential drug candidates. Additionally, it may possess biological activities that could be beneficial for various therapeutic applications, making it an important compound for further investigation and potential pharmaceutical development.
Check Digit Verification of cas no
The CAS Registry Mumber 871700-18-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,1,7,0 and 0 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 871700-18:
(8*8)+(7*7)+(6*1)+(5*7)+(4*0)+(3*0)+(2*1)+(1*8)=164
164 % 10 = 4
So 871700-18-4 is a valid CAS Registry Number.
871700-18-4Relevant articles and documents
5-AMINO-2,4,7-TRIOXO-3,4,7,8-TETRAHYDRO-2H-PYRIDO’2,3-D! PYRIMIDINE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CANCER
-
Page/Page column 144; 149-150, (2008/06/13)
The present invention relates to a pyrimidine compound represented by the following formula [I] wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and a pharmaceutical agent for the prophylaxis or treatment of a disease caused by undesirable cell proliferation, particularly an antitumor agent, which contains such compound. The compound of the present invention has superior undesirable cell proliferation suppressing action, particularly, an antitumor action, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, antirheumatoid agent and the like. In addition, by the combined use with other antitumor agent such as alkylating agent, metabolism antagonist and the like, it can be a more effective antitumor agent.
